Navigation Links
Caraco Pharmaceutical Laboratories, Ltd. Announces G.P. Singh Sachdeva Is Appointed as Chief Operating Officer
Date:7/27/2010

DETROIT, July 27 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD) announced that G.P. Singh Sachdeva was appointed as Chief Operating Officer of the Company by the Board of Directors on July 23, 2010.

Previously, Mr. Singh served as Senior Vice President – Business Strategies of the Company from July 2007 to July 2010.  He also has served as Vice President – Sales and Marketing from September 2003 to July 2007, as well as National Sales and Marketing Manager from September 2000 to September 2003.

Detroit-based Caraco Pharmaceutical Laboratories, Ltd., develops, manufactures, markets and distributes generic pharmaceuticals to the nation's largest wholesalers, distributors, drugstore chains and managed care providers.

Safe Harbor: This news release contains forward-looking statements made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Without limitation, the words "believe" or "expect" and similar expressions are intended to identify forward-looking statements. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties are contained in the Corporation's filings with the Securities and Exchange Commission, including Part I, Item 1A of our most recent Form 10-K, and include but are not limited to: information of a preliminary nature that may be subject to adjustment, potentially not obtaining or delay in obtaining FDA approval for new products, governmental restrictions on the sale of certain products, development by competitors of new or superior products or less expensive products or new technology for the production of products, the entry into the market of new competitors, market and customer acceptance and demand for new pharmaceutical products, availability of raw materials, timing and success of product development and launches, dependence on few products generating majority of sales, product liability claims for which the Company may be inadequately insured, material litigation from product recalls, the purported class action lawsuits alleging federal securities laws violations, delays in returning the Company's products to market, including loss of market share, and other risks identified in this report and from time to time in our periodic reports and registration statements. These forward-looking statements represent our judgment as of the date of this report. We disclaim, however, any intent or obligation to update our forward-looking statements.


'/>"/>
SOURCE Caraco Pharmaceutical Laboratories, Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Flomax®
2. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Wellbutrin SR® Extended Release Tablets
3. Caraco Pharmaceutical Laboratories, Ltd. Receives Notice Regarding NYSE Amex Continued Listing Standards
4. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Optivar®
5. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Exelon® Capsules
6. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Eloxatin(R)
7. Caraco Pharmaceutical Laboratories, Ltd. Markets Nicardipine Hydrochloride Injection
8. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution
9. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution
10. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal Year 2010
11. Caraco Pharmaceutical Laboratories, Ltd. Closes Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro(R) (escitalopram oxalate) ANDA Patent Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/5/2017)... OMAHA, Neb. , June 5, 2017 /PRNewswire/ ... chair in the United States ... chair that helps a fallen person up to an ... is easily assembled and operated by one assistant and ... hand. It is simple enough that a child can ...
(Date:6/1/2017)... Pa. , June 1, 2017 Nutriceutical ... and Veterinarian Recommended Solutions (VRS), and KD Pharma Group ... in Nutriceutical Holdings by KD Pharma Group. KD Pharma ... with the option to acquire the entire company. ... in KD. They are committed to growing the NH ...
(Date:5/30/2017)... Israel , May 30, 2017 Therapix ... pharmaceutical Company specializing in the development of cannabinoid-based ... present a company overview at three upcoming scientific ... 7th Annual LD Micro Invitational: ... Date:                     ...
Breaking Medicine Technology:
(Date:6/28/2017)... ... June 28, 2017 , ... ... and the surrounding regions access to insurance assistance and financial planning services, is ... Ministries to assist families in the region facing financial crisis. , Matthew 25: ...
(Date:6/27/2017)... IL (PRWEB) , ... June 27, 2017 , ... ... considering a cosmetic treatment, according to survey data released today by the ... on Cosmetic Dermatologic Procedures indicates the percentage of consumers considering a cosmetic ...
(Date:6/27/2017)... ... June 27, 2017 , ... The Congressional Budget Office ... repeal and replace the 2010 Patient Protection and Affordable Care Act (ACA), would result ... would be expected under current law. , More than 20 million Americans have gained ...
(Date:6/27/2017)... ... , ... Two residents from the Gardant-managed assisted living and memory care communities ... lawmakers to protect Medicaid funding. , The video, which was produced by the American ... Chuck and Cathy Schwarz, a couple who is still able to see each other ...
(Date:6/27/2017)... ... June 27, 2017 , ... Drs. Gregory Toback and Marianne ... Mystic, CT. Covering the process and maintenance strategies of gum grafting and dental ... procedures. Drs. Toback and Urbanski practice as experienced periodontists in New ...
Breaking Medicine News(10 mins):